`

ImaginAb

Biotechnology Research

Specialities :
Antibody engineering and imaging
Personalized medicine
Therapeutic management
Clinical development
Pet radiopharmaceuticals

+11

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$12.8M
size-icon Size
11 - 50

Frequently Asked Questions About ImaginAb

What does Imaginab do?+

ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products through its proprietary minibody and cys-diabody platforms. The lead candidate 89Zr crefmirlimab berdoxam (CD8 ImmunoPETTM) imaging agent is currently in Phase II clinical trials and has been licensed by numerous pharmaceutical and biotech companies for use in imaging within their immunotherapy clinical trials, primarily in oncology

What are Imaginab's specialties? +

Antibody engineering and imaging,personalized medicine,therapeutic management,clinical development,pet radiopharmaceuticals,89zr-,pet imaging,minibody,biomarker,immunocology,cd8,t cells,immunology,oncology,cancer,and cd8 tracer

What is Imaginab's industry? +

Imaginab operates in the Biotechnology research industry.

What is Imaginab's revenue? +

Imaginab's revenue is 11m - 100m

What is Imaginab's company size? +

Imaginab has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.